T-NeuroDx
PrivateLast Round
Seed
Sep 15, 2025
Total Funding Raised
$1.7M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
T-NeuroDx is a biotechnology company developing blood-based diagnostic biomarker assays for the early detection of Alzheimer's disease.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
T-NeuroDx Comparables
Compare T-NeuroDx with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ALZpath, Inc. | 86% | |
| Neurocode USA, Inc. | 83% | |
| C2N Diagnostics | 77% |
T-NeuroDx Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Sep 15, 2025 | ||||
| Grant | Aug 13, 2025 | ||||
| Seed | May 18, 2021 |
Key People
Founding team and executive leadership
T-NeuroDx Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
| New Mexico Economic Development Department | Seed |
| New Mexico Start-Up Factory | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 58% MoM.
- Jul 26, 2026
Monthly visitors grew 372% MoM, from 260 to 1.2K.
T-NeuroDx Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about T-NeuroDx's valuation, stock price, and market status.
Is T-NeuroDx a public or private company?
T-NeuroDx is a private company.
What is the current stock price of T-NeuroDx?
T-NeuroDx is a private company with no public stock price. No recent secondary market data is available.
How much is T-NeuroDx worth (valuation)?
Valuation information for T-NeuroDx is not publicly available.
Can I buy T-NeuroDx stock?
T-NeuroDx shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was T-NeuroDx's last funding round?
T-NeuroDx's most recent funding round was Seed on September 15, 2025.
Who are the main investors in T-NeuroDx?
Key investors in T-NeuroDx include NIH RADx, New Mexico Economic Development Department, New Mexico Start-Up Factory.
Will T-NeuroDx IPO soon?
No public IPO plans have been announced for T-NeuroDx.
How can I track T-NeuroDx secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor T-NeuroDx's secondary market activity and sign up for updates.